Diagnosing LSE: The Crucial Role of Specialized Ultrasounds
At a Glance
The gold standard for diagnosing Libman-Sacks endocarditis is a transesophageal echocardiogram (TEE). Unlike standard ultrasounds, a TEE provides the high-resolution images necessary to find the small, flat, sterile vegetations on heart valves caused by lupus or antiphospholipid syndrome.
Diagnosing Libman-Sacks Endocarditis (LSE) is a specialized process that requires more than a standard heart ultrasound. Because the growths (vegetations) in LSE are often small, flat, and hidden in hard-to-see areas of the heart, a high-resolution approach is essential to ensure they are not missed [1][2]. Return to the Home Page for an overview.
Why the “Standard” Ultrasound Is Not Enough
Most patients first receive a Transthoracic Echocardiogram (TTE), where an ultrasound probe is placed on the chest. While TTE is a great first step, it often lacks the detail needed to find LSE vegetations [1].
- Distance: In a TTE, the ultrasound waves must travel through skin, muscle, and bone to reach the heart.
- Resolution: Small or flat growths (often less than 5mm to 10mm) can be invisible on a standard TTE [3].
- Hidden Locations: LSE growths often form on the underside of valves or in corners of the heart that the TTE probe cannot easily “see” [4].
The Power of Transesophageal Echocardiography (TEE)
The “gold standard” for identifying LSE is the Transesophageal Echocardiogram (TEE) [1][3]. During this procedure, you are sedated, and a thin tube with a small ultrasound probe is passed down your esophagus (the food pipe), which sits directly behind your heart [1].
- Clearer View: Because the probe is only millimeters away from the heart, the images are incredibly sharp and detailed [3].
- 3D Imaging: Modern TEE often uses 3D-TEE technology, which creates a realistic, three-dimensional reconstruction of your heart valves [5][6]. This helps doctors see the exact shape and size of vegetations and distinguishes them from normal heart structures [7][8].
What Doctors Look For on TEE
On a TEE, Libman-Sacks vegetations have specific characteristics that help your care team identify them:
- Sessile Shape: Unlike the “swinging” or finger-like growths often seen in bacterial infections, LSE vegetations are usually sessile, meaning they are broad-based and sit flat against the valve [4].
- Unique Locations: They are frequently found on both sides of the mitral or aortic valves, or even on the walls of the heart chambers themselves [9][10].
- Valve Thickening: Beyond just seeing growths, TEE can detect subtle thickening or scarring of the valve tissue, which is a common sign of long-term lupus heart disease [11][12].
Complementary Tests for a Full Picture
A diagnosis of LSE is rarely based on heart imaging alone. Your doctors will use several other tools to understand how the condition is affecting your body:
- Brain MRI: Because LSE carries a high risk of tiny, “silent” blood clots traveling to the brain, a brain MRI is often performed to look for signs of small strokes or “lacunar” infarctions that you might not even feel [13][14].
- Blood Markers: Your doctor will check for active markers of Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS), such as anti-dsDNA, lupus anticoagulant, and anti-cardiolipin antibodies [15][16]. High levels of these antibodies are often linked to the formation of these heart valve growths [17][18].
- Blood Cultures: To be absolutely sure the growths are not caused by a bacterial infection, multiple blood cultures will be taken to confirm they are sterile [19].
By combining these high-tech images with detailed blood work and brain scans, your medical team can build a complete map of your health and create the best plan to protect your heart and brain [20][21].
Common questions in this guide
Why do I need a TEE if my standard heart ultrasound (TTE) was normal?
What do Libman-Sacks vegetations look like on an ultrasound?
Why might my doctor order a brain MRI if I have a heart valve issue?
How do blood tests help diagnose Libman-Sacks endocarditis?
Get notified when new evidence is published on Libman-Sacks endocarditis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (21)
- 1
A Contemporary 20-Year Cleveland Clinic Experience of Nonbacterial Thrombotic Endocarditis: Etiology, Echocardiographic Imaging, Management, and Outcomes.
Zmaili MA, Alzubi JM, Kocyigit D, et al.
The American journal of medicine 2021; (134(3)):361-369 doi:10.1016/j.amjmed.2020.06.047.
PMID: 32827467 - 2
The impact of Libman-sacks endocarditis on inpatient outcomes with systemic lupus erythematosus: A retrospective study.
Alfatlawi H, Alharbi A, Shah M, et al.
Lupus 2024; (33(7)):693-699 doi:10.1177/09612033241243179.
PMID: 38564733 - 3
Non-Bacterial Thrombotic Endocarditis as a Cause of Cryptogenic Stroke in Malignancy.
Ilyas S, Lang W, Belani N, Stockwell P
Rhode Island medical journal (2013) 2021; (104(2)):63-66.
PMID: 33648323 - 4
Multivalvular involvement associated with Libman-Sacks endocarditis detected by multimodality imaging: A case report.
Bui STT, Nguyen PH, Nguyen TN, et al.
Frontiers in cardiovascular medicine 2023; (10()):1117711 doi:10.3389/fcvm.2023.1117711.
PMID: 37063968 - 5
Novel 3D versus traditional transesophageal echocardiography techniques: Defining differences in the diagnosis of infective endocarditis.
Tomoaia R, Beyer RȘ, Dădârlat-Pop A, et al.
European journal of clinical investigation 2024; (54(2)):e14103 doi:10.1111/eci.14103.
PMID: 37815038 - 6
An update on intraoperative three-dimensional transesophageal echocardiography.
Rong LQ
Journal of thoracic disease 2017; (9(Suppl 4)):S271-S282 doi:10.21037/jtd.2017.03.123.
PMID: 28540070 - 7
Papillary Fibroelastoma of the Aortic Root Causing Intermittent Coronary Ostial Obstruction: The Diagnostic Power of 3D Transesophageal Echocardiography.
Bečić T, Perković-Avelini R, Fabijanić D
Diagnostics (Basel, Switzerland) 2026; (16(1)) doi:10.3390/diagnostics16010168.
PMID: 41515663 - 8
Role of 3D Echocardiography in Cardiac Surgery: Strengths and Limitations.
Turton EW, Ender J
Current anesthesiology reports 2017; (7(3)):291-298 doi:10.1007/s40140-017-0226-5.
PMID: 28890667 - 9
Mitral valve 'kissing lesion' in Libman-Sacks endocarditis.
Sadeghpour A, Pourafkari L, Nader ND
QJM : monthly journal of the Association of Physicians 2021; (114(5)):338 doi:10.1093/qjmed/hcaa342.
PMID: 33401301 - 10
Libman-Sacks Endocarditis in a Patient With Antiphospholipid Syndrome.
Kotkar KD, Said SM
The Annals of thoracic surgery 2016; (102(1)):e31-2.
PMID: 27343524 - 11
Libman-Sacks Endocarditis Involving a Bioprosthesis in the Aortic Valve Position in Systemic Lupus Erythematosus.
Roberts WC, Lee AY, Lander SR, et al.
The American journal of cardiology 2019; (124(2)):316-318 doi:10.1016/j.amjcard.2019.04.031.
PMID: 31133276 - 12
Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report.
Le Ho Y, Ahmad Zaidi NA, Salleh A, Abdul Kareem BA
Journal of cardiothoracic surgery 2021; (16(1)):92 doi:10.1186/s13019-021-01458-2.
PMID: 33865405 - 13
Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis.
Choi JH, Park JE, Kim JY, Kang T
Korean circulation journal 2016; (46(3)):425-8 doi:10.4070/kcj.2016.46.3.425.
PMID: 27275182 - 14
Neurologic complications of nonbacterial thrombotic endocarditis.
Dafer RM
Handbook of clinical neurology 2021; (177()):135-141 doi:10.1016/B978-0-12-819814-8.00013-5.
PMID: 33632431 - 15
Cardiac Involvement in Systemic Lupus Erythematosus.
Vyas V, Vyas V, Sharma A, Kumar PA
Reviews in cardiovascular medicine 2025; (26(11)):42760 doi:10.31083/RCM42760.
PMID: 41356287 - 16
Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort.
Chen S, Huang C, Jiang H, et al.
Lupus science & medicine 2025; (12(1)) doi:10.1136/lupus-2025-001674.
PMID: 40541268 - 17
Impact of antiphospholipid antibodies on cardiac valve lesions in systemic lupus erythematosus: a systematic review and meta-analysis.
Chen S, Zhou Y, Wang C, et al.
Clinical and experimental medicine 2024; (24(1)):147 doi:10.1007/s10238-024-01406-z.
PMID: 38960899 - 18
Clinical characteristics and long-term outcomes of Libman-Sacks endocarditis in patients with systemic lupus erythematosus.
Yoo BW, Lee SW, Song JJ, et al.
Lupus 2020; (29(9)):1115-1120 doi:10.1177/0961203320930097.
PMID: 32536317 - 19
Case report of culture-negative endocarditis in lupus nephritis.
Khandait H, Ong CK, Javaid A, Sandhu R
European heart journal. Case reports 2023; (7(7)):ytad290 doi:10.1093/ehjcr/ytad290.
PMID: 37457053 - 20
Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
Roldan CA, Sibbitt WL, Greene ER, et al.
PloS one 2021; (16(2)):e0247052 doi:10.1371/journal.pone.0247052.
PMID: 33592060 - 21
Systemic Lupus Erythematosus With Catastrophic APS and Libman-Sacks Endocarditis in a Patient With Autoimmune Hemolytic Anemia: A Case Report.
Ehsan S, Afshar S, Bakhtiari S, et al.
Clinical case reports 2025; (13(12)):e71552 doi:10.1002/ccr3.71552.
PMID: 41341566
This page explains diagnostic tests for Libman-Sacks endocarditis for educational purposes only. Always consult your cardiologist or rheumatologist for medical advice and to help interpret your specific imaging and blood test results.